| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2025 | Jan 22, 2025 | Coherus Oncology, Inc. | CEO | Sell | 36.3 | -11,810 | -0.97% | ✗ | $16.4K |
| Jan 4, 2025 | Jan 7, 2025 | Coherus Oncology, Inc. | CEO | Sell | 36.3 | -11,810 | -0.96% | ✗ | $19.6K |
| Jan 20, 2024 | Jan 23, 2024 | Coherus Oncology, Inc. | CEO | Sell | 36.3 | -11,218 | -0.90% | ✗ | $27.4K |
| Jan 4, 2024 | Jan 8, 2024 | Coherus Oncology, Inc. | CEO | Sell | 36.3 | -11,781 | -0.94% | ✗ | $34.4K |
| Nov 22, 2023 | Nov 24, 2023 | Coherus Oncology, Inc. | CEO | Sell | 20.0 | -223,100 | -15.13% | ✗ | $449.8K |
| Jan 4, 2023 | Jan 6, 2023 | Coherus Oncology, Inc. | CEO | Sell | 32.5 | -10,905 | -0.99% | ✗ | $107.6K |
| Jun 6, 2021 | Jun 8, 2021 | Coherus Oncology, Inc. | CEO | Sell | 20.0 | -31,054 | -2.94% | ✗ | $421.2K |
| Jan 10, 2020 | Jan 14, 2020 | Coherus Oncology, Inc. | CEO | Sell | 92.5 | +38,247 | 5.81% | ✗ | $381.5K |
| Nov 21, 2019 | Nov 25, 2019 | Coherus Oncology, Inc. | CEO | Sell | 22.5 | -12,500 | -1.86% | ✗ | $232K |
| Nov 20, 2019 | Nov 22, 2019 | Coherus Oncology, Inc. | CEO | Sell | 15.0 | -825,000 | -55.14% | ✗ | $14.9M |
| May 30, 2019 | May 31, 2019 | Coherus Oncology, Inc. | CEO | Sell | 20.0 | -32,398 | -2.12% | ✗ | $631.3K |
| Jan 11, 2019 | Jan 15, 2019 | Coherus Oncology, Inc. | CEO | Sell | 82.5 | +32,398 | 2.17% | ✗ | $221K |
| May 16, 2018 | May 17, 2018 | Coherus Oncology, Inc. | Officer | Sell | 20.0 | -20,984 | -1.38% | ✗ | $341.3K |
| Sep 20, 2016 | Sep 22, 2016 | Coherus Oncology, Inc. | CEO | Sell | 40.0 | -4,060 | -0.27% | ✗ | $128.9K |
| Sep 16, 2016 | Sep 20, 2016 | Coherus Oncology, Inc. | CEO | Sell | 47.5 | -2,900 | -0.19% | ✗ | $92.2K |
| Nov 30, 2015 | Dec 2, 2015 | Coherus Oncology, Inc. | CEO | Sell | 51.3 | -400 | -0.03% | ✗ | $12.7K |